Abiopharma

(10% Negative) Legend Biotech (LEGN) Reports Q2 2022 Financial Results (Form 6-K)

(50% Neutral) Marinus Pharmaceuticals, Inc. (MRNS) Announces Regulatory Update

(99% Neutral) PASSAGE BIO, INC. (PASG) Announces New Board Appointment

(10% Negative) RedHill Biopharma (RDHL) Announces Clinical Development Update (Form 6-K)

(99% Neutral) EVELO BIOSCIENCES, INC. (EVLO) Announces New Board Appointment

(10% Negative) Sage Therapeutics, Inc. (SAGE) Announces Delay in importance Trials for depressive symptoms at Day 15 Due to Pandemic-Related Challenges, Regulatory Process, Safety Review, Efficacy Assessment

(90% Positive) Axsome Therapeutics, Inc. (AXSM) Announces Enrollment Update for held Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(99% Neutral) ProQR Therapeutics (PRQR) Announces Clinical Development Update (Form 6-K)

(99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Development Update

(99% Neutral) KAMADA (KMDA) Files Form 6-K